Exposure of macrophages to an enzymatically inactive macrophage mannose receptor ligand augments killing of Candida albicans

Proceedings of the Society for Experimental Biology and Medicine

Volumn 217, Issue 1, 1998, Pages 81-88

  Gelderman, Monique P ^a   Lefkowitz, Doris L ^a   Lefkowitz, Stanley S ^a   Bollen, Alex ^b   Moguilevsky, Nicole ^b  

^a TEXAS TECH UNIVERSITY   (United States)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL CELL; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; FEMALE; INFECTION RISK; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION;

ANIMALS; CANDIDA ALBICANS; CATTLE; CELLS, CULTURED; CHEMILUMINESCENT MEASUREMENTS; FEMALE; LECTINS, C-TYPE; LIGANDS; MACROPHAGES, PERITONEAL; MALE; MANNOSE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; PEROXIDASE; PHAGOCYTOSIS; RECEPTORS, CELL SURFACE; SERUM ALBUMIN; SERUM ALBUMIN, BOVINE;

ANIMALIA; BOVINAE; CANDIDA ALBICANS; LETHRINIDAE; MURINAE;

EID: 0031973427     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Mehta RT, McQueen TJ, Keyhani A, Lopez-Berestein G. Liposomal hamycin: Reduced toxicity and improved antifungal efficacy in vitro and in vivo. J Infect Dis 164:1003-1006, 1991.
2. Thompson HL, Wilton JMA. Interaction and intracellular killing of Candida albicans blastospores by human polymorphonuclear leukocytes, monocytes, and monocyte-derived macrophages in aerobic and anaerobic conditions. Clin Exp Immunol 87:316-321, 1991.
3. Odds FC. Candida species and virulence. ASM News 60:313-318, 1994.
4. Sternberg S. The emerging fungal threat. Science 266:1632-1634, 1994.
5. Fidel PL, Sobel JD. The role of cell-mediated immunity in candidiasis. Trends Microbiol 2:202-206, 1994.
6. Greenberg S, Silverstein SC. Phagocytosis. In: Paul WE, Ed. Fundamental Immunology. New York: Raven Press, pp941-964, 1993.
7. El-Hag A, Lipsky PE, Bennett M, Clark RA. Immunomodulation by neutrophil myeloperoxidase and hydrogen peroxide: Differential susceptibility of human lymphocyte functions. J Immunol 136:3420-3426, 1986.
8. Pryzwansky KB, MacRae EK, Spitznagel JK, Cooney MH. Early degranulation of human neutrophils: Immunocytochemical studies of surface and intracellular phagocytic events. Cell 18:1025-1033, 1979.
9. Bradley PP, Christensen RD, Rothstein G. Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60:618-622, 1982.
10. Moguilevsky N, Garcia-Quintana L, Jacquet A, Tournay C, Fabry L, Pierard L, Bollen A. Structural and biological properties of human recombinant myeloperoxidase produced by Chinese hamster ovary cell lines. Eur J Biochem 197:605-614, 1991.
11. Shepherd VL, Hoidal J. Clearance of neutrophil-derived myeloperoxidase by the macrophage mannose receptor. Am J Respir Cell Mol Biol 2:235-340, 1990.
12. Gordon S, Starkey PM, Hume D, Ezekowitz RAB, Hirsch S, Austyn J. Plasma membrane markers to study differentiation, activation, and localization of murine macrophages: Ag F4/80 and the mannosyl, fucosyl receptor. In: Weir DM, Herzenberg LA, Blackwell C, Herzenberg LA, Eds. Handbook of Experimental Immunology, 2nd edition. Oxford, London: Alden Press, pp43.1-43.15, 1986.
13. Stahl PD. The macrophage mannose receptor and other macrophage lectins. Cur Opin Immunol 4:49-52, 1992.
14. Lefkowitz DL, Mills K, Castro A, Lefkowitz SS. Induction of tumor necrosis factor and macrophage-mediated cytotoxicity by horseradish peroxidase and other glycosylated proteins: The role of enzymatic activity and LPS. J Leukoc Biol 50:615-623, 1991.
15. Lefkowitz DL, Mills KC, Moguilevsky N, Bollen A, Vaz A, Lefkowitz SS. Regulation of macrophage function by human recombinant myeloperoxidase. Immunol Lett 36:43-50, 1993.
16. Mills KC, Lefkowitz DL, Morgan CD, Lefkowitz SS. Induction of cytokines by peroxidases in vivo. Immunol Infect Dis 2:45-50, 1992.
17. Lefkowitz SS, Gelderman MP, Lefkowitz DL, Moguilevsky N, Bollen A. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidases. J Infect Dis 173:1202-1207, 1996.
18. Zabucchi G, Soranzo MR, Menegazzi R, Bertoncin P, Nardon E, Patriarca P. Uptake of human eosinophil peroxidase and myeloperoxidase by cells involved in the inflammatory process. J Histochem Cytochem 37(4):449-508, 1989.
19. King CC, Jefferson MM, Thomas EL. Secretion and inactivation of myeloperoxidase by isolated neutrophils. J Leukoc Biol 61:293-302, 1997.
20. Edwards SW, Hughes V, Barlow J, Bucknall R. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis. J Biochem 250:81-85, 1988.
21. Jacquet A, Deleersnyder V, Garcia-Quintana L, Bollen A, Moguilevsky N. Site-directed mutagenesis of human myeloperoxidase: A topological approach to the heme-binding site. Fed Eur Biochem Soc 302:189-191, 1992.
22. Krawisz JE, Sharon P, Stenson WF. Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1322-1350, 1984.
23. Lefkowitz DL, Lefkowitz SS, Wei RQ, Everse J. Activation of macrophages with oxidative enzymes. In: DiSabato G, Everse J, Eds. Methods in Enzymology. Orlando: Academic Press, pp537-548, 1986.
24. Schuit KE. Phagocytosis and intracellular killing of pathogenic yeasts by human monocytes and neutrophils. Infect Immun 24:932-938, 1979.
25. Peterson KP, Gaziano E, Suh HJ, Devalon M, Peterson L, Keane WF. Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun 49:212-218, 1985.
26. Lian C-J, Hwang WS, Pai CH. Plasmid-mediated resistance to phagocytosis in Yersinia enterolitica. Infect Immun 55:1176-1183, 1987.
27. Sasada M, Johnston RB. Macrophage microbicidal activity. J Exp Med 152:85-98, 1980.
28. Lincoln J, Lefkowitz DL, Cain T, Castro A, Lefkowitz SS, Moguilevsky N, Bollen A. Exogenous myeloperoxidase enhances bacterial phagocytosis and intracellular killing by macrophages. Infect Immun 63:3042-3047, 1995.
29. Leung K-P, Goren MB. Uptake and utilization of human polymorphonuclear leukocyte granule myeloperoxidase by mouse peritoneal macrophages. Cell Tissue Res 257:653-656, 1989.
30. Jacquet A, Deby C, Mathy M, Moguilevsky N, Deby-Dupont G, Thirion A, Goormaghtigh E, Garcia-Quintana A, Bollen A, Pincemail J. Spectral and enzymatic properties of human recombinant myeloperoxidase: Comparison with the mature enzyme. Arch Biochem Biophys 291:132-138, 1991.
31. Sung SJ, Nelson RS, Silverstein SC. Yeast mannans inhibit binding and phagocytosis of zymosan by mouse peritoneal macrophages. J Cell Biol 96:160-166, 1983.
32. Lang T, de Chastellier C. Fluid phase and mannose receptor-mediated uptake of horseradish peroxidase in mouse bone marrow-derived macrophages: Biochemical and ultrastructural study. Biol Cell 53:149-154, 1985.
33. Jacquet A, Garcia-Quintana L, Deleersnyder V, Fenna R, Bollen A, Moguilevsky N. Site-directed mutagenesis of human myeloperoxidase: Further identification of residues involved in catalytic activity and heme interaction. Biochem Biophys Res Comm 202:73-81, 1994.
34. Taylor ME, Bezouska K, Drickamer K. Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor. J Biol Chem 3:1719-1726, 1992.
35. Taylor ME, Drickamer K. Structural requirements for high affinity binding of complex ligands by the macrophage mannose receptor. J Biol Chem 1:399-404, 1993.
36. Hiral K, Moriguchi K, Wang GY. Human neutrophils produce free radicals from the cell-zymosan interface during phagocytosis and from the whole plasma membrane when stimulated with calcium ionophore A23187. Exp Cell Res 194:19-27, 1991.
37. Edwards SW, Nurcombe HL, Hart CA. Oxidative inactivation of myeloperoxidase released from human neutrophils. Biochem J 245:925-928, 1987.